Agilon Health Valuation
| AGL Stock | USD 3.09 0.13 4.39% |
At this time, the firm appears to be overvalued. agilon health shows a prevailing Real Value of $2.71 per share. The current price of the firm is $3.09. Our model approximates the value of agilon health from analyzing the firm fundamentals such as Operating Margin of (0.09) %, current valuation of 924.11 M, and Return On Equity of -0.43 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Agilon Health's valuation include:
Price Book 2.2146 | Enterprise Value | Enterprise Value Ebitda (104.52) | Price Sales 0.2276 | Forward PE 178.5714 |
Overvalued
Today
Please note that Agilon Health's price fluctuation is dangerous at this time. Calculation of the real value of agilon health is based on 3 months time horizon. Increasing Agilon Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Agilon stock is determined by what a typical buyer is willing to pay for full or partial control of agilon health. Since Agilon Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Agilon Stock. However, Agilon Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.09 | Real 2.71 | Target 2.89 | Hype 3.09 | Naive 3.84 |
The intrinsic value of Agilon Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Agilon Health's stock price.
Estimating the potential upside or downside of agilon health helps investors to forecast how Agilon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Agilon Health more accurately as focusing exclusively on Agilon Health's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Agilon Health's intrinsic value based on its ongoing forecasts of Agilon Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Agilon Health's closest peers.
Agilon Health Cash |
|
Agilon Valuation Trend
Knowing Agilon Health's actual value is paramount for traders when making sound investment determinations. Using both Agilon Health's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Agilon Valuation Data Drivers
Agilon Revenue by Product
Agilon Health Total Value Analysis
agilon health is presently forecasted to have company total value of 924.11 M with market capitalization of 1.27 B, debt of 52.31 M, and cash on hands of 497.07 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Agilon Health fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
924.11 M | 1.27 B | 52.31 M | 497.07 M |
Agilon Health Investor Information
About 98.0% of the company shares are held by institutions such as insurance companies. The book value of Agilon Health was presently reported as 1.4. The company has Price/Earnings To Growth (PEG) ratio of 0.19. agilon health recorded a loss per share of 0.76. The entity last dividend was issued on the February 17, 2016. The firm had 2:1 split on the December 4, 1995. agilon health is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Agilon Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Agilon Health has an asset utilization ratio of 247.94 percent. This suggests that the Company is making $2.48 for each dollar of assets. An increasing asset utilization means that agilon health is more efficient with each dollar of assets it utilizes for everyday operations.Agilon Health Ownership Allocation
The majority of agilon health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in agilon health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Agilon Health. Please pay attention to any change in the institutional holdings of agilon health as this could imply that something significant has changed or is about to change at the company.Agilon Health Profitability Analysis
The company reported the last year's revenue of 4.32 B. Reported Net Loss for the year was (262.8 M) with loss before taxes, overhead, and interest of (51.77 M).About Agilon Health Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of agilon health. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of agilon health based exclusively on its fundamental and basic technical indicators. By analyzing Agilon Health's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Agilon Health's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Agilon Health. We calculate exposure to Agilon Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Agilon Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 80.1 M | 83.8 M | |
| Pretax Profit Margin | (0.04) | (0.04) | |
| Operating Profit Margin | (0.05) | (0.05) | |
| Net Loss | (0.05) | (0.06) | |
| Gross Profit Margin | 0.02 | 0.02 |
Agilon Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as Agilon Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 408.9 M | |
| Quarterly Earnings Growth Y O Y | 11.951 | |
| Forward Price Earnings | 178.5714 |
Agilon Health Current Valuation Indicators
Agilon Health's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Agilon Health's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Agilon Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Agilon Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Agilon Health's worth.When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.951 | Earnings Share (0.76) | Revenue Per Share | Quarterly Revenue Growth 0.276 | Return On Assets |
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.